Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Human leukocyte antigen-B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis.

Ugolotti E, Vanni I, Raso A, Benzi F, Malnati M, Biassoni R.

Hum Immunol. 2011 Oct;72(10):859-68. doi: 10.1016/j.humimm.2011.05.007.

PMID:
21664941
2.

HLA-B and HLA-C Supratyping by Pyrosequencing®.

Vanni I, Ugolotti E, Larghero P, Biassoni R.

Methods Mol Biol. 2015;1315:133-51. doi: 10.1007/978-1-4939-2715-9_11.

PMID:
26103897
3.

An improved method for HLA-B and -C supratyping.

Biassoni R, Malnati S, Vanni I, Raso A, Sironi F, Broccolo F, Garbarino L, Mazzocco M, Montera M, Larghero P, Di Marco E, Ugolotti E.

J Immunol Methods. 2015 Nov;426:29-34. doi: 10.1016/j.jim.2015.07.008.

PMID:
26232127
4.

Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.

Levinson RD, Du Z, Luo L, Monnet D, Tabary T, Brezin AP, Zhao L, Gjertson DW, Holland GN, Reed EF, Cohen JH, Rajalingam R.

Genes Immun. 2008 Apr;9(3):249-58. doi: 10.1038/gene.2008.13.

PMID:
18340360
5.

KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.

Tajik N, Shahsavar F, Poormoghim H, Radjabzadeh MF, Mousavi T, Jalali A.

Int J Immunogenet. 2011 Oct;38(5):403-9. doi: 10.1111/j.1744-313X.2011.01024.x.

PMID:
21797986
6.

NK-KIR ligand identification: a quick Q-PCR approach for HLA-C epitope typing.

Schellekens J, Rozemuller EH, Borst HP, Otten HG, van den Tweel JG, Tilanus MG.

Tissue Antigens. 2007 Apr;69(4):334-7.

PMID:
17389017
7.

The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.

Saunders PM, Vivian JP, Baschuk N, Beddoe T, Widjaja J, O'Connor GM, Hitchen C, Pymm P, Andrews DM, Gras S, McVicar DW, Rossjohn J, Brooks AG.

J Immunol. 2015 Jan 15;194(2):781-9. doi: 10.4049/jimmunol.1402542.

8.

A small test of a sequence-based typing method: definition of the B*1520 allele.

Domena JD, Little AM, Arnett KL, Adams EJ, Marsh SG, Parham P.

Tissue Antigens. 1994 Oct;44(4):217-24.

PMID:
7871522
9.

Unexpected Bw4 and Bw6 reactivity patterns in new alleles.

Voorter CE, van der Vlies S, Kik M, van den Berg-Loonen EM.

Tissue Antigens. 2000 Oct;56(4):363-70.

PMID:
11098937
10.

Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction.

Grifoni A, Montesano C, Patronov A, Colizzi V, Amicosante M.

Biomed Res Int. 2013;2013:283805. doi: 10.1155/2013/283805.

11.

HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation.

López-Alvarez MR, Moya-Quiles MR, Minguela A, Gil J, Miras M, Campillo JA, Díaz-Alderete MA, García-Alonso AM, Sánchez-Bueno F, Vicario JL, Muro M, Alvarez-López MR.

Transplantation. 2009 Aug 15;88(3 Suppl):S54-61. doi: 10.1097/TP.0b013e3181af7d84.

PMID:
19667963
12.

Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population.

López-Vázquez A, Miña-Blanco A, Martínez-Borra J, Njobvu PD, Suárez-Alvarez B, Blanco-Gelaz MA, González S, Rodrigo L, López-Larrea C.

Hum Immunol. 2005 Mar;66(3):285-9.

PMID:
15784466
13.

Rhesus macaque KIR bind human MHC class I with broad specificity and recognize HLA-C more effectively than HLA-A and HLA-B.

Older Aguilar AM, Guethlein LA, Hermes M, Walter L, Parham P.

Immunogenetics. 2011 Sep;63(9):577-85. doi: 10.1007/s00251-011-0535-7.

14.

Mapping of an epitope defined by a human hybridoma antibody (TrD3): a new HLA-B supertype associated with a subset of HLA-Bw6.

Kolstad A, Toubert A, Weyl D, Jun G, Hannestad K.

Hum Immunol. 1992 Jun;34(2):77-84.

PMID:
1385373
15.

Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations.

Lopez-Larrea C, Blanco-Gelaz MA, Torre-Alonso JC, Bruges Armas J, Suarez-Alvarez B, Pruneda L, Couto AR, Gonzalez S, Lopez-Vázquez A, Martinez-Borra J.

Arthritis Res Ther. 2006;8(4):R101.

16.

Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802].

Arnett KL, Adams EJ, Gumperz JE, Darke C, Marsh SG, Gelsthorpe K, Parham P.

Tissue Antigens. 1995 Oct;46(4):316-21.

PMID:
8560451
17.

Human leukocyte antigen Bw4 and Bw6 epitopes recognized by antibodies and natural killer cells.

Lutz CT.

Curr Opin Organ Transplant. 2014 Aug;19(4):436-41. doi: 10.1097/MOT.0000000000000103. Review.

PMID:
24977435
18.
19.

Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.

O'Connor GM, Vivian JP, Widjaja JM, Bridgeman JS, Gostick E, Lafont BA, Anderson SK, Price DA, Brooks AG, Rossjohn J, McVicar DW.

J Immunol. 2014 Mar 15;192(6):2875-84. doi: 10.4049/jimmunol.1303142.

20.

Serological mapping of HLA-epitopes with monoclonal antibodies and its interpretation by sequenced HLA-molecules.

Harpprecht J, Olde K, Westphal E, Müller-Ruchholtz W.

Tissue Antigens. 1989 Sep;34(3):170-8.

PMID:
2480657

Supplemental Content

Support Center